Bakhu Holdings Corp. has entered into significant agreements to address its financial and reporting deficiencies. A Memorandum of Understanding (MOU) was initially signed on March 17, 2026, with Phytocyte Pty Ltd. and Inter-M Traders FZ-LLE, outlining funding and corporate governance changes. Phytocyte agreed to provide up to $600,000 via an interest-free convertible promissory note to cover creditors, vendors, service providers, delinquent SEC filings, and taxes. This MOU was terminated on April 17, 2026, due to insufficient funding terms following an SEC inquiry. A subsequent Binding Heads of Agreement was entered into on April 7, 2026, with Phytocyte Pty Ltd. for up to $250,000 in funding. This new agreement aims to restore the company to good standing, regularize filings, and implement a change of control. Phytocyte's funding will be used for SEC compliance, accounting, tax, legal, and corporate restoration expenses. Upon satisfaction of a Compliance Restoration Milestone, Phytocyte's funding will convert into 70% of Bakhu's outstanding common stock. The company has also appointed new directors and officers, including Konstantia (Nadia) Galazi as President, CEO, Secretary, and CFO, and Karl E. Watkin as a director. Qi CPA LLC has been engaged as the new registered public accounting firm. The company received an inquiry from the SEC on March 24, 2026, regarding its non-compliance and failure to file mandatory reports, to which it responded with an intent to become current.